(1 - 11 von 12
)
DKTK :: Targeted countermeasure for altering tumors
dktk.dkfz.de
“In some of these cancers, the drug Olaparib has been successfully implemented to prevent cancer cells from DNA repair, causing a programmed cell death” says Stefan Duensing from the Department of Urology at the Heidelberg University Hospital.
Medications that target metastasing tumours - Healthcare industry
www.gesundheitsindustrie-bw.de
Jan 18, · An interdisciplinary study led by Prof. Stefan Duensing, which also involved researchers from the Institute of Pathology at the Heidelberg University Hospital, the Department of Urology at the Heidelberg University Hospital and the NCT, has now demonstrated the efficacy of PARP inhibitors for treating prostate cancer in patients with defective ...
sortiert nach Relevanz / Datum